«Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states». Drugs46 (2): 313–40. 1993. doi:10.2165/00003495-199346020-00008. PMID7691519.
Miotto, Karen; Cho, Arthur K.; Khalil, Mohamed A.; Blanco, Kirsten; Sasaki, Jun D.; Rawson, Richard (January 2017). «Trends in Tramadol». Anesthesia & Analgesia124 (1): 44–51. doi:10.1213/ANE.0000000000001683. PMID27861439.
«Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain». Current Medical Research and Opinion26 (1): 239–51. 2010. doi:10.1185/03007990903426787. PMID19929615.
«Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur». Drug Alcohol Depend69 (3): 233–41. April 2003. doi:10.1016/S0376-8716(02)00321-6. PMID12633909.
«Tramadol deaths in Northern Ireland: a review of cases from 1996 to 2012». Journal of Forensic and Legal Medicine23: 32–36. 2014. doi:10.1016/j.jflm.2014.01.006. PMID24661703.
Miotto, Karen; Cho, Arthur K.; Khalil, Mohamed A.; Blanco, Kirsten; Sasaki, Jun D.; Rawson, Richard (2017). «Trends in Tramadol». Anesthesia & Analgesia124 (1): 44–51. doi:10.1213/ANE.0000000000001683. PMID27861439.
Vazzana, M; Andreani, T; Fangueiro, J; Faggio, C; Silva, C; Santini, A; Garcia, ML; Silva, AM και άλλοι. (March 2015). «Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems.». Biomedicine & Pharmacotherapy70: 234–8. doi:10.1016/j.biopha.2015.01.022. PMID25776506.
«Pharmacological aspects of the effects of tramadol on G-protein coupled receptors». J. Pharmacol. Sci.103 (3): 253–60. 2007. doi:10.1254/jphs.cr0060032. PMID17380034.
«Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems». Biomed. Pharmacother.70: 234–8. 2015. doi:10.1016/j.biopha.2015.01.022. PMID25776506.
«Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor». Naunyn Schmiedebergs Arch. Pharmacol.362 (2): 116–21. 2000. doi:10.1007/s002100000266. PMID10961373.
«Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine». European Journal of Pharmacology349 (2–3): 199–203. May 1998. doi:10.1016/S0014-2999(98)00195-2. PMID9671098.
«p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro». Journal of Neurochemistry82 (6): 1435–43. September 2002. doi:10.1046/j.1471-4159.2002.01073.x. PMID12354291.
«Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser». Eur. J. Pharmacol.370 (1): 23–6. 1999. doi:10.1016/s0014-2999(99)00123-5. PMID10323276.
«Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol». Biochem. Pharmacol.47 (12): 2289–93. 1994. doi:10.1016/0006-2952(94)90267-4. PMID8031323.
«NADAC as of 2018-12-19». Centers for Medicare and Medicaid Services. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Δεκεμβρίου 2018. Ανακτήθηκε στις 22 Δεκεμβρίου 2018.
medicinescomplete.com
Brayfield, A, επιμ. (13 Δεκεμβρίου 2013). «Tramadol Hydrochloride». Martindale: The Complete Drug Reference. Pharmaceutical Press. Ανακτήθηκε στις 5 Απριλίου 2014.
«Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states». Drugs46 (2): 313–40. 1993. doi:10.2165/00003495-199346020-00008. PMID7691519.
Miotto, Karen; Cho, Arthur K.; Khalil, Mohamed A.; Blanco, Kirsten; Sasaki, Jun D.; Rawson, Richard (January 2017). «Trends in Tramadol». Anesthesia & Analgesia124 (1): 44–51. doi:10.1213/ANE.0000000000001683. PMID27861439.
«Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain». Current Medical Research and Opinion26 (1): 239–51. 2010. doi:10.1185/03007990903426787. PMID19929615.
«"Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine». Prescrire International25 (168): 45–50. Feb 2016. ISSN1167-7422. PMID27042732.
«Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur». Drug Alcohol Depend69 (3): 233–41. April 2003. doi:10.1016/S0376-8716(02)00321-6. PMID12633909.
«Tramadol deaths in Northern Ireland: a review of cases from 1996 to 2012». Journal of Forensic and Legal Medicine23: 32–36. 2014. doi:10.1016/j.jflm.2014.01.006. PMID24661703.
Miotto, Karen; Cho, Arthur K.; Khalil, Mohamed A.; Blanco, Kirsten; Sasaki, Jun D.; Rawson, Richard (2017). «Trends in Tramadol». Anesthesia & Analgesia124 (1): 44–51. doi:10.1213/ANE.0000000000001683. PMID27861439.
Vazzana, M; Andreani, T; Fangueiro, J; Faggio, C; Silva, C; Santini, A; Garcia, ML; Silva, AM και άλλοι. (March 2015). «Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems.». Biomedicine & Pharmacotherapy70: 234–8. doi:10.1016/j.biopha.2015.01.022. PMID25776506.
«Pharmacological aspects of the effects of tramadol on G-protein coupled receptors». J. Pharmacol. Sci.103 (3): 253–60. 2007. doi:10.1254/jphs.cr0060032. PMID17380034.
«Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems». Biomed. Pharmacother.70: 234–8. 2015. doi:10.1016/j.biopha.2015.01.022. PMID25776506.
«Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor». Naunyn Schmiedebergs Arch. Pharmacol.362 (2): 116–21. 2000. doi:10.1007/s002100000266. PMID10961373.
«Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine». European Journal of Pharmacology349 (2–3): 199–203. May 1998. doi:10.1016/S0014-2999(98)00195-2. PMID9671098.
«p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro». Journal of Neurochemistry82 (6): 1435–43. September 2002. doi:10.1046/j.1471-4159.2002.01073.x. PMID12354291.
«Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser». Eur. J. Pharmacol.370 (1): 23–6. 1999. doi:10.1016/s0014-2999(99)00123-5. PMID10323276.
«Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol». Biochem. Pharmacol.47 (12): 2289–93. 1994. doi:10.1016/0006-2952(94)90267-4. PMID8031323.
«NADAC as of 2018-12-19». Centers for Medicare and Medicaid Services. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Δεκεμβρίου 2018. Ανακτήθηκε στις 22 Δεκεμβρίου 2018.
«"Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine». Prescrire International25 (168): 45–50. Feb 2016. ISSN1167-7422. PMID27042732.